Veradermics, Inc. board member Patrick G. Enright has reported significant stock disposals, reflecting ongoing changes in the pharmaceutical industry.
| Name | Veradermics, Inc |
|---|---|
| CIK | 0001827635 |
| Tickers | MANE |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 843304423 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 228.372.3376 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Veradermics, Inc. board member Patrick G. Enright has reported significant stock disposals, reflecting ongoing changes in the pharmaceutical industry.
Veradermics, Inc has filed its Q3 2026 report, revealing key financial insights and operational updates critical for stakeholders in the pharmaceutical industry.
Veradermics announces its Q3 2026 financial results, showcasing progress in clinical trials for VDPHL01, a potential hair loss treatment.
Veradermics, Inc. reveals positive topline data from its Phase 2/3 trial of VDPHL01, a treatment for pattern hair loss, boosting its market position.
Veradermics, Inc. announced positive Phase 3 trial results for VDPHL01, a treatment for hair loss, potentially reshaping the pharmaceutical market.
104 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-461091 | 005-95484 | 261554302 | 34 | 22377 | |||
| 2026-11-13 | 4 | 4 | 0001193125-26-461090 | 7711 | ||||||
| 2026-11-13 | 4 | 4 | 0001193125-26-461071 | 10304 | ||||||
| 2026-11-12 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-457122 | 001-43097 | 261543717 | 33 | 5072 | |||
| 2026-11-10 | 10-Q | 10-Q | 0001827635-26-000043 | 001-43097 | 261541326 | 34 | 6926529 | 1 | 1 | |
| 2026-11-10 | 8-K | 8-K | 2.02,9.01 | 0001827635-26-000041 | 001-43097 | 261538282 | 34 | 641608 | 1 | 1 |
| 2026-11-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001827635-26-000038 | 001-43097 | 261534099 | 34 | 7954417 | 1 | 1 |
| 2026-10-19 | 8-K | 8-K | 7.01,8.01,9.01 | 0001827635-26-000036 | 001-43097 | 261467665 | 34 | 7437880 | 1 | 1 |
| 2026-10-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000019617-26-000348 | 005-95484 | 261456257 | 34 | 6753 | |||
| 2026-09-03 | 4 | FORM 4 | 0001628280-26-060491 | 7455 | ||||||
| 2026-08-21 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000899140-26-000948 | 005-95484 | 261306016 | 34 | 35034 | |||
| 2026-08-21 | 4 | FORM 4 | 0000899140-26-000947 | 41869 | ||||||
| 2026-08-20 | 3 | FORM 3 | 0001628280-26-058305 | 11588 | ||||||
| 2026-08-19 | 144 | xsl144X01/primary_doc.xml | 0000899140-26-000905 | 001-43097 | 261296852 | 33 | 5284 | |||
| 2026-08-19 | 144 | xsl144X01/primary_doc.xml | 0000899140-26-000904 | 001-43097 | 261296849 | 33 | 5310 | |||
| 2026-08-18 | 4 | FORM 4 | 0001628280-26-057816 | 15540 | ||||||
| 2026-08-18 | 4 | FORM 4 | 0001628280-26-057813 | 15549 | ||||||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000850 | 001-43097 | 261287768 | 33 | 5366 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001968582-26-000848 | 001-43097 | 261287732 | 33 | 5260 | |||
| 2026-08-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002672 | 333-298150 | 261284614 | 33 | 1783 | ||
| 2026-08-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001072613-26-000686 | 005-95484 | 261284398 | 34 | 143901 | |||
| 2026-08-14 | 144/A | xsl144X01/primary_doc.xml | 0001628280-26-057202 | 001-43097 | 261284221 | 33 | 4660 | |||
| 2026-08-14 | 4 | FORM 4 | 0001628280-26-057196 | 10168 | ||||||
| 2026-08-14 | 424B3 | 424B3 | 0001628280-26-057174 | 333-298150 | 261283420 | 33 | 571263 | |||
| 2026-08-12 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-056395 | 001-43097 | 261269102 | 33 | 4830 | |||
| 2026-08-12 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-056391 | 001-43097 | 261269099 | 33 | 4758 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001827635-26-000030 | 001-43097 | 261263899 | 34 | 6668299 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001827635-26-000028 | 001-43097 | 261260715 | 34 | 641730 | 1 | 1 |
| 2026-08-07 | S-1 | S-1 | 0001628280-26-054921 | 333-298150 | 261255325 | 33 | 886524 | 1 | 1 | |
| 2026-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002159 | 005-95484 | 261247264 | 34 | 11350 | |||
| 2026-07-15 | 8-K | 8-K | 7.01,8.01,9.01 | 0001827635-26-000023 | 001-43097 | 261176056 | 34 | 6574002 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000905148-26-002434 | 005-95484 | 26990060 | 34 | 36589 | |||
| 2026-05-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001827635-26-000020 | 021-584260 | 26985583 | 33 | 19768 | ||
| 2026-05-12 | 10-Q | 10-Q | 0001827635-26-000019 | 001-43097 | 26969735 | 34 | 5629995 | 1 | 1 | |
| 2026-05-12 | 8-K | 8-K | 2.02,9.01 | 0001827635-26-000016 | 001-43097 | 26966019 | 34 | 626206 | 1 | 1 |
| 2026-05-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-057224 | 005-95484 | 26954311 | 34 | 27156 | |||
| 2026-05-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000899140-26-000416 | 005-95484 | 26945543 | 34 | 16963 | |||
| 2026-05-05 | 4 | xslF345X06/form4.xml | 0000899140-26-000415 | 34769 | ||||||
| 2026-05-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-207186 | 005-95484 | 26945465 | 34 | 23515 | |||
| 2026-05-05 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001013594-26-000528 | 005-95484 | 26945316 | 34 | 29321 | |||
| 2026-05-05 | 3 | FORM 3 | 0001013594-26-000527 | 5903 | ||||||
| 2026-05-01 | 8-K | 8-K | 1.01,3.02,9.01 | 0001628280-26-029376 | 001-43097 | 26933182 | 34 | 621869 | 1 | 1 |
| 2026-04-30 | 424B4 | 424B3 | 0001628280-26-029027 | 333-295356 | 26927431 | 33 | 2584115 | |||
| 2026-04-30 | FWP | FWP | 0001628280-26-028546 | 333-295356 | 26919601 | 34 | 46638 | |||
| 2026-04-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001392 | 333-295356 | 26919629 | 33 | 1782 | ||
| 2026-04-29 | S-1MEF | S-1MEF | 0001628280-26-028544 | 333-295420 | 26919545 | 33 | 314043 | 1 | 1 | |
| 2026-04-27 | FWP | FWP | 0001628280-26-027639 | 333-295356 | 26902258 | 34 | 46700 | |||
| 2026-04-27 | CORRESP | filename1.htm | 0001628280-26-027635 | 10409 | ||||||
| 2026-04-27 | CORRESP | filename1.htm | 0001628280-26-027634 | 17837 | ||||||
| 2026-04-27 | S-1 | S-1 | 0001628280-26-027631 | 333-295356 | 26902137 | 33 | 3402896 | 1 | 1 | |
| 2026-04-27 | 8-K | 8-K | 2.02 | 0001628280-26-027629 | 001-43097 | 26902124 | 34 | 144137 | 1 | 1 |
| 2026-04-27 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-26-027354 | 001-43097 | 26896873 | 34 | 6755319 | 1 | 1 |
| 2026-04-07 | UPLOAD | filename1.pdf | 0000000000-26-003484 | 377-09225 | 40066 | |||||
| 2026-04-06 | DRS | filename1.htm | 0001628279-26-000454 | 377-09225 | 26840647 | 33 | 2532294 | |||
| 2026-03-30 | 10-K | 10-K | 0001827635-26-000013 | 001-43097 | 26813671 | 34 | 68899506 | 1 | 1 | |
| 2026-03-30 | 8-K | 8-K | 2.02,9.01 | 0001827635-26-000010 | 001-43097 | 26810121 | 34 | 252803 | 1 | 1 |
| 2026-02-27 | 4/A | FORM 4/A | 0001027035-26-000004 | 5750 | ||||||
| 2026-02-12 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-049157 | 005-95484 | 26628047 | 34 | 151492 | |||
| 2026-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000905148-26-000680 | 005-95484 | 26627310 | 34 | 39972 | |||
| 2026-02-11 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0000899140-26-000173 | 005-95484 | 26622100 | 34 | 125556 | |||
| 2026-02-11 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001193125-26-046658 | 005-95484 | 26621197 | 34 | 341056 | |||
| 2026-02-09 | 4 | xslF345X05/form4.xml | 0000899140-26-000140 | 75079 | ||||||
| 2026-02-09 | 3 | xslF345X02/form3.xml | 0000899140-26-000139 | 26150 | ||||||
| 2026-02-05 | 4 | 4 | 0001193125-26-039876 | 5175 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005910 | 9105 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005909 | 6125 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005907 | 35530 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005906 | 19544 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005905 | 24784 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005904 | 21701 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005903 | 5540 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005900 | 5610 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005899 | 5609 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005898 | 10511 | ||||||
| 2026-02-05 | 4 | FORM 4 | 0001628280-26-005897 | 9347 | ||||||
| 2026-02-05 | S-8 | S-8 | 0001628280-26-005859 | 333-293238 | 26604001 | 33 | 415093 | 1 | 1 | |
| 2026-02-05 | 8-K | 8-K | 5.03,9.01 | 0001628280-26-005800 | 001-43097 | 26603224 | 34 | 171512 | ||
| 2026-02-04 | 424B4 | 424B4 | 0001628280-26-005505 | 333-292657 | 26599354 | 33 | 37827005 | |||
| 2026-02-04 | CERT | NYSE CERTIFICATION | 0000876661-26-000084 | 001-43097 | 26595936 | 34 | 384781 | |||
| 2026-02-03 | 3 | 3 | 0001193125-26-036425 | 24075 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005249 | 12762 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005248 | 11904 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005247 | 22456 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005246 | 16281 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005245 | 13949 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005244 | 16894 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005243 | 7357 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005242 | 14327 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005241 | 18182 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005240 | 24969 | ||||||
| 2026-02-03 | 3 | FORM 3 | 0001628280-26-005239 | 23712 | ||||||
| 2026-02-03 | S-1MEF | S-1MEF | 0001628280-26-005218 | 333-293180 | 26595575 | 33 | 274868 | 1 | 1 | |
| 2026-02-03 | 8-A12B | 8-A12B | 0001628280-26-005106 | 001-43097 | 26594490 | 34 | 17930 | |||
| 2026-02-03 | FWP | FWP | 0001827635-26-000005 | 333-292657 | 26589941 | 34 | 22525 | |||
| 2026-01-30 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000407 | 333-292657 | 26585552 | 33 | 1782 | ||
| 2026-01-28 | S-1/A | S-1/A | 0001628280-26-003764 | 333-292657 | 26570273 | 33 | 41480854 | 1 | 1 | |
| 2026-01-09 | S-1 | S-1 | 0001628280-26-001651 | 333-292657 | 26523842 | 33 | 38336763 | 1 | 1 | |
| 2025-10-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-25-000361 | 021-562294 | 251424336 | 33 | 10982 | ||
| 2025-10-27 | DRS | filename1.htm | 0001628279-25-000707 | 377-08614 | 251417292 | 33 | 6926316 | |||
| 2024-12-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001827635-24-000001 | 021-531652 | 241538171 | 33 | 10925 | ||
| 2023-05-01 | D | xslFormDX01/primary_doc.xml | 06b | 0001827635-23-000002 | 021-480424 | 23870604 | 33 | 8918 | ||
| 2021-10-07 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001827635-21-000004 | 021-415905 | 211312202 | 33 | 9431 | ||
| 2021-10-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001827635-21-000003 | 021-415905 | 211309562 | 33 | 6822 | ||
| 2020-10-09 | D | xslFormDX01/primary_doc.xml | 06b | 0001827635-20-000001 | 021-377538 | 201232489 | 33 | 6666 |
One latest value per concept from companyfacts (153 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 42.20M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 0 | 2025-06-30 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 234,326.95 | 2026-08-07 | S-1 | 2026-08-07 | 0001628280-26-054921 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 234,326.95 | 2026-08-07 | S-1 | 2026-08-07 | 0001628280-26-054921 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 1.70B | 2026-08-07 | S-1 | 2026-08-07 | 0001628280-26-054921 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-07 | S-1 | 2026-08-07 | 0001628280-26-054921 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-07 | S-1 | 2026-08-07 | 0001628280-26-054921 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 1.96M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 8.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 2.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -3.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 994.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 4.09M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 12.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 5.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 1,202 | 2025-03-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | Assets | Assets | USD | 807.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 805.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 798.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001827635-26-000019 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001827635-26-000019 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 217.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 215.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001827635-26-000019 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 | USD | 0 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001827635-26-000019 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 795.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 581.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 580.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 666.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 132.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 798.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 132.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 110.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2026-05-31 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001827635-26-000030 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 42.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 42.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -74.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 4.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | -3.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 770.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 6.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 24.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 187,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 4.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 522,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 36.46M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.242 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.003 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.059 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.035 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 16.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 32.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -71.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 1.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 16.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -14.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 219,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.48M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -212,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncreaseDecreaseInAccruedInterestReceivableNet | Increase (Decrease) in Accrued Interest Receivable, Net | USD | 3.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 1.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 406,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -38,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -3.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 25,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 12.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | Liabilities | Liabilities | USD | 10.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 807.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 10.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 713.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -544.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -58.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -71.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -74.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -74.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 16.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 88.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -88.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 371,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 1.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 180.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 602,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-12 | 0001827635-26-000019 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -3.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -3.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 297,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -108,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 4.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 1.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 27.70M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 638.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 367,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 25.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 7.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 362,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 269.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 414.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 28.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ProceedsFromOtherEquity | Proceeds from Other Equity | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 94.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 386,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 55.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -195.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 694,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 151.00M | 2025-10-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 12.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.847 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.77 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.045 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.036 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 796.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.099 | 2026-01-27 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | StockholdersEquityNoteSubscriptionsReceivable | Stockholders' Equity Note, Subscriptions Receivable | USD | 596,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001827635-26-000030 | |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 300,000 | 2026-08-01 | 2026-08-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 264.48M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 414.33M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 1.33M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable | Temporary Equity, Shares Subscribed but Unissued, Subscriptions Receivable | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 21.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-30 | 0001827635-26-000013 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 35.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 35.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001827635-26-000043 |